People online are using it to supercharge their metabolism and potentially extend their lifespan.
A new calculation could be more accurate than BMI and could change how we measure obesity.
We’ve known obesity to be a trainwreck when it comes to health: it’s linked to heart trouble, diabetes, chronic illness, and more.
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines.
I N THE SPACE of less than a decade, medicine acquired a means of doing what millennia of diets and exhortation could not.
The market leader in obesity shots, Lilly hasn’t made a major dent in the pill market yet.
Phase III data supported setmelanotide's recent label expansion in acquired hypothalamic o .
If you cannot lose weight, do not give up.
America gets supersized as obesity rates spike in both children and adults - Rising obesity rates have been tied to a more sedentary lifestyle and ultraprocessed diet .
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis .
A review suggests that although obesity medications, such as GLP-1 drugs, can result in substantial weight loss, many obesity drugs do not improve quality of life or heart health.
A cohort study indicates prepregnancy BMI and race, ethnicity interact to influence the prevalence and risk for preeclampsia, eclampsia.